MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
Country |
 USA |
IPO year |
2019 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
60.5 M |
Market Cap[1] |
$ 76.9 M |
EBITDA (LTM) |
$ -222 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
-1.07 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
Amphastar Pharmaceuticals
AMPH
|
$ 21.94 | 2.45 % | $ 1.03 B | Nasdaq Global Select Market | USA |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market |  China |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Aptorum Group Limited
APM
|
$ 0.91 | 1.96 % | $ 6.69 M | Nasdaq Global Select Market | China |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market |  France |
 |
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market | France |
 |
ACADIA Pharmaceuticals
ACAD
|
$ 22.73 | 3.51 % | $ 3.77 B | Nasdaq Global Select Market,SPB | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Esperion Therapeutics
ESPR
|
$ 1.98 | 3.4 % | $ 412 M | Nasdaq Global Market,SPB | USA |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
Galectin Therapeutics
GALT
|
$ 2.46 | 5.58 % | $ 157 M | Nasdaq Global Select Market | USA |
 |
Greenwich LifeSciences
GLSI
|
$ 24.14 | -0.29 % | $ 314 M | Nasdaq Capital Market | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Heron Therapeutics
HRTX
|
$ 1.23 | 2.94 % | $ 205 M | Nasdaq Global Select Market,SPB | USA |
 |
ImmuCell Corporation
ICCC
|
$ 8.22 | -1.56 % | $ 74.2 M | Nasdaq Global Select Market | USA |
 |
Allakos
ALLK
|
- | - | $ 28.6 M | Nasdaq Global Select Market,SPB | USA |
 |
InflaRx N.V.
IFRX
|
$ 1.56 | 5.07 % | $ 152 M | Nasdaq Global Select Market | Germany |
 |
AlloVir
ALVR
|
- | 4.14 % | $ 49.1 M | Nasdaq Global Select Market | USA |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Innate Pharma S.A.
IPHA
|
$ 1.4 | 1.09 % | $ 235 M | Nasdaq Global Select Market | France |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market |  Canada |
 |
Brainstorm Cell Therapeutics
BCLI
|
- | -2.5 % | $ 5.88 M | Nasdaq Capital Market | USA |
 |
Applied Therapeutics
APLT
|
- | - | $ 8.42 M | Nasdaq Global Market,SPB | USA |
 |
Aptinyx
APTX
|
- | -39.0 % | $ 4.57 M | Nasdaq Global Select Market | USA |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
Aravive
ARAV
|
- | -13.39 % | $ 1.45 M | Nasdaq Global Select Market | USA |
 |
Inventiva S.A.
IVA
|
$ 5.11 | -0.78 % | $ 138 M | Nasdaq Global Market | France |
 |
Jaguar Health
JAGX
|
$ 0.33 | -13.82 % | $ 770 K | Nasdaq Capital Market | USA |
 |
Aridis Pharmaceuticals
ARDS
|
- | 17.91 % | $ 11.1 M | Nasdaq Capital Market | USA |
 |
BioNTech SE
BNTX
|
$ 102.65 | -2.66 % | $ 27.2 B | Nasdaq Global Select Market | Germany |
 |
Avenue Therapeutics
ATXI
|
- | -52.27 % | $ 4.45 M | Nasdaq Global Select Market | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
KalVista Pharmaceuticals
KALV
|
$ 20.05 | 2.11 % | $ 1.08 B | Nasdaq Global Select Market | Britain |
 |
Aquestive Therapeutics
AQST
|
$ 4.14 | 1.59 % | $ 443 M | Nasdaq Global Market | USA |
 |
Arcutis Biotherapeutics
ARQT
|
$ 23.65 | 1.68 % | $ 3.01 B | Nasdaq Global Select Market,SPB | USA |
 |
Ayala Pharmaceuticals
AYLA
|
- | - | $ 7.46 M | Nasdaq Global Market |  Israel |
 |
Autolus Therapeutics plc
AUTL
|
$ 1.44 | -0.35 % | $ 383 M | Nasdaq Global Select Market | Britain |
 |
Aptose Biosciences
APTO
|
- | -45.71 % | $ 1.2 M | Nasdaq Capital Market | Canada |
 |
AstraZeneca PLC
AZN
|
- | - | $ 96.9 B | Nasdaq Global Select Market | Britain |
 |
AVROBIO
AVRO
|
- | 1083.1 % | $ 745 M | Nasdaq Global Select Market | USA |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
$ 230.83 | -0.19 % | $ 4.22 B | Nasdaq Global Select Market,SPB | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 2.92 | 0.24 % | $ 4.81 M | NYSE American | Israel |
 |
Eli Lilly and Company
LLY
|
$ 881.74 | -0.28 % | $ 791 B | NYSE,SPB | USA |
 |
BioDelivery Sciences International
BDSI
|
- | -4.8 % | $ 255 M | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.